C F Abildgaard. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anticoagulants/therapeutic useBlood Cell CountBlood Coagulation TestsBlood PlateletsChild, PreschoolErythrocyte Aggregation/complicationsErythrocyte Aggregation/diagnosisErythrocyte Aggregation/drug therapyErythrocyte Aggregation/etiologyFactor V/analysisFactor VIII/analysisFibrinogen/analysisHemangioma/complicationsHemolysisHeparin/therapeutic useHumansInfant, NewbornInfant, Newborn, Diseases/complicationsInfections/complicationsLeukemia/complicationsNeoplasms/complicationsPurpura/complicationsPurpura, Thrombotic Thrombocytopenic/complicationsThrombocytopenia/complicationsUremia/complications
Substances: See more » AnticoagulantsFactor VFactor VIIIFibrinogenHeparin
Year: 1969 PMID: 5812568 DOI: 10.1016/s0022-3476(69)80064-8
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406